July 22, 2022
THURSDAY, July 21 (STAT News) — The Biden administration has selected Monica Bertagnolli, a renowned surgical oncologist, as the next director of the National Cancer Institute, according to two sources familiar with the decision.
Bertagnolli, currently a surgeon at Dana-Farber Cancer Center and a professor at Harvard Medical School, will take the reins of the country’s largest biomedical research institute — a $7 billion agency that funds the lion’s share of U.S. cancer research and is central to the White House’s “Cancer Moonshot.”
Why are so many Black patients dying of skin cancer?
July 21, AAMC
Regular Screening Pays Off for People at High Risk for Pancreatic Cancer
July 20, U.S News & World Report
How gut bacteria could boost cancer treatments
July 19, Nature
Breast cancer survivor launches app to spread self-screening knowledge
July 18, Spectrum News 1
Earlier this year, President Biden reignited the Cancer Moonshot with renewed leadership and ambitious goals to ‘end cancer as we know it.’ To address colorectal cancer, the White House has been working with national advocacy organization Fight Colorectal Cancer (Fight CRC) and other advocacy and industry leaders in the colorectal cancer community. On July 25, 2022, Carolyn “Bo” Aldigé, founder of the Prevent Cancer Foundation, and 18 others will join Fight CRC at the White House to discuss their shared response to the President’s call to action to improve and increase access to colorectal cancer screening, with a special emphasis on reaching the underserved and the 44 million people who need to be screened.